CERT

Certara (CERT)

About Certara (CERT)

Certara, Inc. engages in the provision of software and technology-enabled services for drug developers. It offers cell and gene therapy, clinical pharmacology, complex biologics, decision analytics and modeling, drug development and regulatory strategy, and model-based analysis services. The company was founded on June 27, 2017, and is headquartered in Radnor, PA.

Details

Daily high

$11.12

Daily low

$10.46

Price at open

$10.59

52 Week High

$19.87

52 Week Low

$9.41

Market cap

1.8B

Dividend yield

0.00%

Volume

684

Avg. volume

1.0M

P/E ratio

-56.43

Certara News